Dahlmann, M.; Monks, A.; Harris, E.D.; Kobelt, D.; Osterland, M.; Khaireddine, F.; Herrmann, P.; Kemmner, W.; Burock, S.; Walther, W.;
et al. Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer. Cancers 2022, 14, 37.
https://doi.org/10.3390/cancers14010037
AMA Style
Dahlmann M, Monks A, Harris ED, Kobelt D, Osterland M, Khaireddine F, Herrmann P, Kemmner W, Burock S, Walther W,
et al. Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer. Cancers. 2022; 14(1):37.
https://doi.org/10.3390/cancers14010037
Chicago/Turabian Style
Dahlmann, Mathias, Anne Monks, Erik D. Harris, Dennis Kobelt, Marc Osterland, Fadi Khaireddine, Pia Herrmann, Wolfgang Kemmner, Susen Burock, Wolfgang Walther,
and et al. 2022. "Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer" Cancers 14, no. 1: 37.
https://doi.org/10.3390/cancers14010037
APA Style
Dahlmann, M., Monks, A., Harris, E. D., Kobelt, D., Osterland, M., Khaireddine, F., Herrmann, P., Kemmner, W., Burock, S., Walther, W., Shoemaker, R. H., & Stein, U.
(2022). Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer. Cancers, 14(1), 37.
https://doi.org/10.3390/cancers14010037